Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade C 29.32 0.10% 0.03
CRY closed up 0.1 percent on Monday, May 20, 2019, on 54 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CRY trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 0.10%
Stochastic Reached Oversold Weakness 0.10%
Multiple of Ten Bearish Other 0.10%
Oversold Stochastic Weakness 0.10%
200 DMA Resistance Bearish -2.36%
20 DMA Resistance Bearish -2.36%
Multiple of Ten Bullish Other -2.36%
Up 3 Days in a Row Strength -2.36%

Older signals for CRY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Medicine Surgery Laser Circulatory System Transplantation End Stage Renal Disease Hemodialysis Cardiovascular System Bypass Vascular Surgery Coronary Artery Disease A Solution Treatment Of Coronary Artery Disease
Is CRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 36.05
52 Week Low 23.99
Average Volume 226,382
200-Day Moving Average 30.2971
50-Day Moving Average 29.6452
20-Day Moving Average 30.4185
10-Day Moving Average 30.489
Average True Range 0.9448
ADX 16.55
+DI 20.5938
-DI 29.3801
Chandelier Exit (Long, 3 ATRs ) 29.7556
Chandelier Exit (Short, 3 ATRs ) 29.6144
Upper Bollinger Band 32.6004
Lower Bollinger Band 28.2366
Percent B (%b) 0.25
BandWidth 14.345875
MACD Line 0.0637
MACD Signal Line 0.3184
MACD Histogram -0.2547
Fundamentals Value
Market Cap 980.64 Million
Num Shares 33.4 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 88.85
Price-to-Sales 3.65
Price-to-Book 3.05
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.85
Resistance 3 (R3) 30.78 30.20 30.60
Resistance 2 (R2) 30.20 29.81 30.24 30.51
Resistance 1 (R1) 29.76 29.57 29.98 29.83 30.42
Pivot Point 29.18 29.18 29.29 29.22 29.18
Support 1 (S1) 28.74 28.79 28.96 28.81 28.22
Support 2 (S2) 28.16 28.55 28.20 28.13
Support 3 (S3) 27.72 28.16 28.05
Support 4 (S4) 27.79